Home
|
Learning Center
|
中文版
Publications
站内成果搜索:
搜索
A phylogenetic study of the generic relationships within the subtribe Leucophoropterina Schuh (Miridae: Phylinae: Leucophoropterini)
A phase II study of the EGFR inhibitor gefitinib in patients with acute myeloid leukemia
A phase II study of the potent PARP inhibitor, Rucaparib (PF-01367338, AG014699), with temozolomide in patients with metastatic melanoma demonstrating evidence of chemopotentiation
A physical simulation of longitudinal seam welding in micro channel tube extrusion
A phase 1 Bayesian dose selection study of bortezomib and sunitinib in patients with refractory solid tumor malignancies
A phenotypic analysis shows that eosinophilic esophagitis is a progressive fibrostenotic disease
A phase II trial of dacomitinib, an oral pan-human EGF receptor (HER) inhibitor, as first-line treatment in recurrent and/or metastatic squamous-cell carcinoma of the head and neck
A phase I study of decitabine and rapamycin in relapsed/refractory AML
A phylogenetic blueprint for a modern whale
A phylogenetic solution to the Acacia problem
A phase II study of gemcitabine, carboplatin and bevacizumab for the treatment of platinum-sensitive recurrent ovarian cancer
A phase I study of sorafenib and vorinostat in patients with advanced solid tumors with expanded cohorts in renal cell carcinoma and non-small cell lung cancer
A phase-field model for elastically anisotropic polycrystalline binary solid solutions
A phase I trial of the IGF-1R antibody Cixutumumab in combination with temsirolimus in patients with metastatic breast cancer
A phase II trial of gemcitabine, irinotecan and panitumumab in advanced cholangiocarcinoma
A phase II study of sorafenib (BAY 43-9006) in recurrent diffuse large B cell lymphoma: an eastern cooperative oncology group study (E1404)
A phase 1 study of a chimeric monoclonal antibody against interleukin-6, siltuximab, combined with docetaxel in patients with metastatic castration-resistant prostate cancer
A phase 1b clinical trial evaluating sifalimumab, an anti-IFN-alpha monoclonal antibody, shows target neutralisation of a type I IFN signature in blood of dermatomyositis and polymyositis patients
A phase 2 study of intravenous panobinostat in patients with castration-resistant prostate cancer
A phase II study evaluating the feasibility of a 5-week cycle of S-1 plus irinotecan (IRIS) in patients with advanced and recurrent colorectal cancer
A phase II trial of oral gimatecan for recurrent glioblastoma
A phase 1 study of prasugrel in patients with sickle cell disease: Effects on biomarkers of platelet activation and coagulation
A photoactivatable drug-caged fluorophore conjugate allows direct quantification of intracellular drug transport
A phylomedicine approach to understanding the evolution of auditory sensory perception and disease in mammals
A phase 1 study evaluating the combination of an allosteric AKT inhibitor (MK-2206) and trastuzumab in patients with HER2-positive solid tumors
A phase I dose-escalation study of intravenous panobinostat in patients with lymphoma and solid tumors
A phase 1 trial of intravenous 4-(N-(S-glutathionylacetyl)amino) phenylarsenoxide (GSAO) in patients with advanced solid tumours
A physics-based model to predict micro-pitting lives of lubricated point contacts
A phase 1b study of placenta-derived mesenchymal stromal cells in patients with idiopathic pulmonary fibrosis
A phylogenetic approach to study the origin and evolution of plasmodesmata-localized glycosyl hydrolases family 17
A phase 2 trial of HQK-1001 in HbE-beta thalassemia demonstrates HbF induction and reduced anemia
A phase II study of cixutumumab (IMC-A12, NSC742460) in advanced hepatocellular carcinoma
A phenylalanine rotameric switch for signal-state control in bacterial chemoreceptors
A phase II placebo-controlled study of tralokinumab in moderate-to-severe asthma
A phase II study of amrubicin and carboplatin for previously untreated patients with extensive-disease small cell lung cancer
A phase I dose-finding, safety and tolerability study of AZD8330 in patients with advanced malignancies
A phase transition in the first passage of a Brownian process through a fluctuating boundary with implications for neural coding
A physics-based temperature model for ultrasonic vibration-assisted pelleting of cellulosic biomass
A phase 1 study of concomitant high-dose lenalidomide and 5-azacitidine induction in the treatment of AML
A phase II trial of a surgical protocol to decrease the incidence of wound complications in obese gynecologic oncology patients
A phase I study of pegylated liposomal doxorubicin and temsirolimus in patients with refractory solid malignancies
A photonic crystal biosensor assay for ferritin utilizing iron-oxide nanoparticles
A photon-photon collider in a vacuum hohlraum
A phylogenetic overview of the antrodia clade (Basidiomycota, Polyporales)
A phase I trial to determine the safety, pharmacokinetics, and pharmacodynamics of intercalated BMS-690514 with paclitaxel/carboplatin (PC) in advanced or metastatic solid malignancies
A phase I dose escalation study of Ad GV.EGR.TNF.11D (TNFerade (TM) Biologic) with concurrent chemoradiotherapy in patients with recurrent head and neck cancer undergoing reirradiation
A phenome-guided drug repositioning through a latent variable model
A photoluminescent interpenetrating metal-organic frame work based on Cu4I4 and novel azino-quinoline ligand
A phenanthroline derivative as exciton blocking material for organic solar cells
A physicochemical investigation of membrane fouling in cold microfiltration of skim milk
A phase I study of pulse high-dose vorinostat (V) plus rituximab (R), ifosphamide, carboplatin, and etoposide (ICE) in patients with relapsed lymphoma
A physically based approach for the estimation of root-zone soil moisture from surface measurements
A physiological basis for control of a prosthetic hand
A phosphotyrosine switch determines the antitumor activity of ER beta
A phenolic ester from Aglaia loheri leaves reveals cytotoxicity towards sensitive and multidrug-resistant cancer cells
A phase 2a trial of 12-week interferon-free therapy with two direct-acting antivirals (ABT-450/r, ABT-072) and ribavirin in IL28B C/C patients with chronic hepatitis C genotype 1
A phylogenetic revision of Hawaiian Pseudocyphellaria sensu lato (lichenized Ascomycota: Lobariaceae) reveals eight new species and a high degree of inferred endemism
A phase II flexible screening design allowing for interim analysis and comparison with historical control
A phase II study of weekly neoadjuvant chemotherapy followed by radical chemoradiation for locally advanced cervical cancer
A phase I clinical trial combining dendritic cell vaccination with adoptive T cell transfer in patients with stage IV melanoma
A phase II clinical trial of a natural formulation containing tea catechins for xerostomia
A phase II study of erlotinib in gemcitabine refractory advanced pancreatic cancer
A phase I trial of arsenic trioxide chemoradiotherapy for infiltrating astrocytomas of childhood
A phase diagram of neutral polyampholyte - from solution to tough hydrogel
A phase II study of gemcitabine and cisplatin plus sorafenib in patients with advanced biliary adenocarcinomas
A phase 2 study of filibuvir in combination with pegylated IFN alfa and ribavirin for chronic HCV
A phase I study of combination vaccine treatment of five therapeutic epitope-peptides for metastatic colorectal cancer; safety, immunological response, and clinical outcome
A phosphate-centric paradigm for pathophysiology and therapy of chronic kidney disease
A phase I study of IMP321 and gemcitabine as the front-line therapy in patients with advanced pancreatic adenocarcinoma
A phase II study of erlotinib monotherapy in pre-treated non-small cell lung cancer without EGFR gene mutation who have never/light smoking history: Re-evaluation of EGFR gene status (NEJ006/TCOG0903)
A phthalate family oxygenase reductase supports terpene alcohol oxidation by CYP238A1 from Pseudomonas putida KT2440
A phase II study of induction carboplatin and gemcitabine followed by chemoradiotherapy for the treatment of locally advanced nasopharyngeal carcinoma
A phase 2 single-center study of carfilzomib 56 mg/m(2) with or without low-dose dexamethasone in relapsed multiple myeloma
A phylogeny of the Gochnatieae: Understanding a critically placed tribe in the Compositae
A phase 2, multicentre, single-arm, open-label study to evaluate the safety and efficacy of single-agent lenalidomide (Revlimid (R)) in subjects with relapsed or refractory peripheral T-cell non-Hodgkin lymphoma: The EXPECT trial
A phase II randomized vehicle-controlled trial of intradermal allogeneic fibroblasts for recessive dystrophic epidermolysis bullosa
A phase Ib study investigating the combination of everolimus and dovitinib in vascular endothelial growth factor refractory clear cell renal cancer
A physics-based scoring function for protein structural decoys: Dynamic testing on targets of CASP-ROLL
A physicochemical process for fabricating submicrometre calcium iron phosphate spheres
A phase II study of five peptides combination with oxaliplatin-based chemotherapy as a first-line therapy for advanced colorectal cancer (FXV study)
A phosphine-mediated stereocontrolled synthesis of Z-enediynes by a vicinal dialkynylation of ethynylphosphonium salts
A pharmacogenetic study of aldehyde oxidase I in patients treated with XK469
A phase I, open-label, single-arm study for QT assessment of eribulin mesylate in patients with advanced solid tumors